Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cell Death Mechanisms in Cerebral Ischemia–Reperfusion Injury

Published:2022-08-17 Issue:12 Volume:47 Page:3525-3542
ISSN:0364-3190
Container-title:Neurochemical Research
language:en
Short-container-title:Neurochem Res

Author:

Zhang Qian,Jia Meng,Wang YunFu,Wang Qun,Wu Jianping

Funder

Natural Science Foundation of Beijing

Beijing Natural Science Foundation

Capital Health Research and Development of Special grants

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,General Medicine,Biochemistry

Link

https://link.springer.com/content/pdf/10.1007/s11064-022-03697-8.pdf

Reference155 articles.

1. GBD (2016) Stroke Collaborators (2019) Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:439–458. https://doi.org/10.1016/S1474-4422(19)30034-1

2. Powers WJ (2020) Acute ischemic stroke. N Engl J Med 383:252–260. https://doi.org/10.1056/NEJMcp1917030

3. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP, Council AHAS (2009) Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/ American Stroke Association. Stroke 40:2945–2948. https://doi.org/10.1161/STROKEAHA.109.192535

4. IST-3 Collaborative Group, Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A (2012) The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): A randomised controlled trial. Lancet 379:2352–2363. https://doi.org/10.1016/S0140-6736(12)60768-5

5. Kalogeris T, Baines CP, Krenz M, Korthuis RJ (2012) Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol 298:229–317. https://doi.org/10.1016/B978-0-12-394309-5.00006-7

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naoxintong capsule accelerates mitophagy in cerebral ischemia-reperfusion injury via TP53/PINK1/PRKN pathway based on network pharmacology analysis and experimental validation;Journal of Ethnopharmacology;2025-01

2. Neuroprotection on ischemic brain injury by Mg2+/H2 released from endovascular Mg implant;Bioactive Materials;2024-12

3. Hydrogen sulfide plays an important role by regulating microRNA in different ischemia–reperfusion injury;Biochemical Pharmacology;2024-11

4. ML218 modulates calcium binding protein, oxidative stress, and inflammation during ischemia-reperfusion brain injury in mice;European Journal of Pharmacology;2024-11

5. Therapeutic potential of fucoidan in central nervous system disorders: A systematic review;International Journal of Biological Macromolecules;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3